HCA Healthcare, Inc. HCA
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.85B | 20.23B | 19.11B | 19.51B | 19.16B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.85B | 20.23B | 19.11B | 19.51B | 19.16B |
| Cost of Revenue | 11.40B | 11.18B | 11.14B | 11.34B | 11.15B |
| Gross Profit | 8.45B | 9.05B | 7.97B | 8.18B | 8.02B |
| SG&A Expenses | -- | -- | -- | 1.03B | -- |
| Depreciation & Amortization | 954.00M | 944.00M | 930.00M | 911.00M | 889.00M |
| Other Operating Expenses | 4.55B | 5.04B | 4.18B | 3.06B | 4.16B |
| Total Operating Expenses | 16.91B | 17.16B | 16.25B | 16.34B | 16.20B |
| Operating Income | 2.94B | 3.07B | 2.86B | 3.18B | 2.97B |
| Income Before Tax | 2.37B | 2.49B | 2.29B | 2.67B | 2.42B |
| Income Tax Expenses | 521.00M | 564.00M | 430.00M | 509.00M | 515.00M |
| Earnings from Continuing Operations | 1.85B | 1.93B | 1.86B | 2.16B | 1.90B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -270.00M | -231.00M | -237.00M | -285.00M | -260.00M |
| Net Income | 1.58B | 1.70B | 1.62B | 1.88B | 1.64B |
| EBIT | 2.94B | 3.07B | 2.86B | 3.18B | 2.97B |
| EBITDA | 3.90B | 4.01B | 3.79B | 4.09B | 3.85B |
| EPS Basic | 7.36 | 7.70 | 7.25 | 8.14 | 7.05 |
| Normalized Basic EPS | 5.61 | 5.99 | 5.34 | 5.89 | 5.38 |
| EPS Diluted | 7.27 | 7.62 | 7.15 | 8.14 | 6.96 |
| Normalized Diluted EPS | 5.54 | 5.93 | 5.26 | 5.89 | 5.30 |
| Average Basic Shares Outstanding | 214.59M | 220.54M | 223.59M | 230.71M | 232.89M |
| Average Diluted Shares Outstanding | 217.21M | 222.83M | 226.65M | 230.71M | 236.18M |
| Dividend Per Share | 0.78 | 0.78 | 0.78 | 0.72 | 0.72 |
| Payout Ratio | 10.45% | 10.06% | 11.30% | 8.63% | 10.10% |